Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intracranial hypertension following intrathecal administration of liposomal cytarabine.

× No keyword cloud information.

14 in total

1. A pharmacokinetic study of intra-CSF administered encapsulated cytarabine (DepoCyt) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase III study.

Authors: Surasak Phuphanich; Bernard Maria; Rene Braeckman; Marc Chamberlain
Journal: J Neurooncol Date: 2006-08-29 Impact factor: 4.130

2. Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia.

Authors: Elias Jabbour; Susan O'Brien; Hagop Kantarjian; Guillermo Garcia-Manero; Alessandra Ferrajoli; Farhad Ravandi; Maria Cabanillas; Deborah A Thomas
Journal: Blood Date: 2007-01-05 Impact factor: 22.113

3. Re: Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia.

Authors: Marc C Chamberlain; Michael J Glantz
Journal: Blood Date: 2007-09-01 Impact factor: 22.113

4. Intrathecal liposomal cytarabine for prevention of meningeal disease in patients with acute lymphocytic leukemia and high-grade lymphoma.

Authors: Brian McClune; Francis K Buadi; Naveed Aslam; Donna Przepiorka
Journal: Leuk Lymphoma Date: 2007-09

5. Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis.

Authors: M J Glantz; S LaFollette; K A Jaeckle; W Shapiro; L Swinnen; J R Rozental; S Phuphanich; L R Rogers; J C Gutheil; T Batchelor; D Lyter; M Chamberlain; B L Maria; C Schiffer; R Bashir; D Thomas; W Cowens; S B Howell
Journal: J Clin Oncol Date: 1999-10 Impact factor: 44.544

1. Rare case of symptomatic empty sella syndrome in a patient treated with intrathecal chemotherapy for acute myeloid leukemia.

Authors: Rahul Khamar; Raees Lunat; Jonathon Kyriakides; Ruhaid Khurram
Journal: Radiol Case Rep Date: 2020-09-06

1 in total

Intracranial hypertension following intrathecal administration of liposomal cytarabine.

1. A pharmacokinetic study of intra-CSF administered encapsulated cytarabine (DepoCyt) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase III study.

2. Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia.

3. Re: Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia.

4. Intrathecal liposomal cytarabine for prevention of meningeal disease in patients with acute lymphocytic leukemia and high-grade lymphoma.

5. Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis.

Review 6. Intrathecal chemotherapy for hematologic malignancies: drugs and toxicities.

7. Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis.

8. Pseudotumor cerebri associated with corticosteroid withdrawal in inflammatory bowel disease.

9. Pharmacokinetics of intralumbar DTC-101 for the treatment of leptomeningeal metastases.

10. Benign intracranial hypertension following corticosteroid withdrawal in childhood.

1. Rare case of symptomatic empty sella syndrome in a patient treated with intrathecal chemotherapy for acute myeloid leukemia.